Luminex technology for anti-HLA antibody screening: Evaluation of performance and of impact on laboratory routine

Cytometry Part B - Clinical Cytometry

Volumn 72, Issue 6, 2007, Pages 465-471

  Colombo, Maria Bernadette ^a   Haworth, Simone Elisabeth ^a   Poli, Francesca ^a   Nocco, Angela ^a   Puglisi, Giuseppe ^a   Innocente, Annalisa ^a   Serafini, Marta ^a   Messa, Piergiorgio ^a   Scalamogna, Mario ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Complement dependent cytotoxicity (CDC) test; HLA specific antibody detection; Luminex technology

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN M ANTIBODY;

ADULT; ANTIBODY SCREENING; ANTIBODY SPECIFICITY; ARTICLE; BLOOD SAMPLING; COMPLEMENT DEPENDENT CYTOTOXICITY; COMPUTER PROGRAM; CONTROLLED STUDY; DEVICE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LABORATORY TEST; LYMPHOCYTE SUBPOPULATION; MALE; MEDICAL TECHNOLOGY; METHODOLOGY; PRIORITY JOURNAL; SENSITIZATION;

ADOLESCENT; ADULT; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODY SPECIFICITY; CHILD; CHILD, PRESCHOOL; CYTOTOXICITY TESTS, IMMUNOLOGIC; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INFANT; KIDNEY TRANSPLANTATION; MASS SCREENING;

EID: 36049041319     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20353     Document Type: Article

References (18)

1. Patel R, Terasaki PI. Significance of the positive cross-match test in kidney transplantation. N Engl J Med 1969;280:735-739.
2. Terasaki PI, Kreisler M, Mickey RM. Presensitization and kidney transplant failures. Postgrad Med J 1971;47:89-100.
3. Terasaki PI, Ozawa M. Predictive value of HLA antibodies and serum creatinine in chronic rejection: Results of a 2-year prospective trial. Transplantation 2005;80:1194-1197.
4. Terasaki PI, Cai J. Humoral theory of transplantation: Further evidence. Curr Opin Immunol 2005;17:541-545.
5. Worthington JE, Thomas AA, Dyer PA, Martin S. Detection of HLA specific antibodies by PRA-STAT and their association with transplant outcome. Transplantation 1998;65:121-125.
6. Pei R, Wang G, Tarsitani C, Rojo S, Chen T, Takemura S, Liu A, Lee J. Simultaneous HLA Class I and Class II antibody screening with flow cytometry. Hum Immunol 1998;59:313-322.
7. Slavcev A, Lacha J, Honsova E, Saidlova H, Lodererova A, Vitkos S, Valhova S, Striz I, Ivaskova E. Clinical relevance of antibodies to HLA antigens undetectable by the standard complement-dependent cytotoxicity test. Transpl Int 2003;16:872-878.
8. Gebel HM, Bray RA, Ruth JA, Zibari GB, McDonald JC, Kahan BD, Kerman RH. Flow PRA to detect clinically relevant HLA antibodies. Transplant Proc 2001;33:477.
9. Christiaans MH, Overhof R, ten Haaft A, Nieman F,van Hooff JP, van den Berg-Loonen EM. No advantage of flow cytometry cross-match over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipients. Transplantation 1996;62:1341-1347.
10. Kimball P, Rhodes C, King A, Ham J, Posner M. Flow cross-matching identifies patients at risk for postoperative elaboration of cytotoxic antibodies. Transplantation 1998;65:444-446.
11. Scornik JC, Clapp W, Patton PR, Van der Wert WJ, Hemming AW, Reed AI, Howard RJ. Outcome of kidney transplants in patients known to be flow cytometry cross-match positive. Transplantation 2001;71:1098-1102.
12. Cardillo M, Poli F, Barraco F, De Fazio N, Rossini G, Boschiero L, Nocera A, Rigotti P, Marchini F, Zacchello G, Zanon G, Mandrini S, Chiaramonte S, Maresca C, Caldara R, Messa P, Berardinelli L, Ambrosini A, Montanaro D, Rampino T, Minetti E, Gotti E, Ghio L, Ginevri F, Albertario F, Scalamogna M. Renal transplantation. Strategies to prevent organ rejection - The role of an inter-regional reference center. Contrib Nephrol 2005;146:1-10.
13. Terasaki PI, McCelland JD. Microdroplet assay of human serum cytotoxins. Nature 1964;998-1000.
14. Vasilescu ER, Ho EK, Colovai AI. Alloantibodies and the outcome of cadaver kidney allografts. Hum Immunol 2006;67:597-604.
15. Pei R, Lee JH, Shih NJ, Chen M, Terasaki PI. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 2003;75:43-49.
16. Morales-Buenrostro E, Buzo-Romero JM, de Leo C, Lopez M, Ortiz-Arroyo VM, Perez-Garrido J, Herrera-Garcia C, Ganados J, Alberu J. Prevalence of HLA antibodies and its impact on graft function in a group of kidney transplant recipients: A cross-sectional study. Transplant Proc 2006;38:899-902.
17. Magee B, Martin J, Middleton D. The repercussions of implementing flow cytometry as a single HLA antibody screening technique in prospective renal transplant recipients. Transpl Int 2006;19:105-109.
18. Tardif GN, McCalmon RT Jr. Successful renal transplantation in the presence of donor specific HLA IgM antibodies. Transplant Proc 1995;27:664-665.